Capricorn Fund Managers’s Pacific Biosciences PACB Stock Holding History

Capricorn Fund Managers’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.58M	Buy	+1,932,623	New	+$2.73M	0.43%	73

Other funds holding PACB

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Advisornet Financial Minnetonka, Minnesota $2.21B AUM 14.38% 1-Year Est. Return

Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

HUB Investment Partners Austin, Texas $5.8B AUM 24.38% 1-Year Est. Return

Abacus Planning Group Columbia, South Carolina $830M AUM 16.3% 1-Year Est. Return

Evolution Wealth Advisors Aventura, Florida $960M AUM 20.9% 1-Year Est. Return

Capricorn Fund Managers's PACB Position: Q3 2026 in Review

Capricorn Fund Managers opened a new position in Pacific Biosciences (PACB) in Q3 2026: 1,932,623 shares worth $4.58M. The stake represents 0.43% of the portfolio and ranks #73 among its holdings.

46 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

Capricorn Fund Managers held 1,932,623 shares of Pacific Biosciences worth $4.58M as of Q3 2026.
Pacific Biosciences was a new Capricorn Fund Managers position in Q3 2026.
Pacific Biosciences made up 0.43% of Capricorn Fund Managers's portfolio in Q3 2026, its #73 holding.
46 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Capricorn Fund Managers's 13F filing for Q3 2026, filed 3 Nov 2026.